Literature DB >> 10766088

Colorectal high-grade adenomas: incidence, localization and adenoma-adenocarcinoma ratio in a retrospective and comparative population-based study of 225 consecutive cases between 1988 and 1996.

R Scheiden1, J Sand, M Pandin, Y Wagener, C Capesius.   

Abstract

Colorectal high-grade adenomas can be regarded as precancerous lesions. This study collected epidemiological data from a defined region (Luxembourg) that can serve as reference data for designing a national screening program for early colorectal cancer detection. Nine pathologists diagnosed and reviewed slides retrospectively from 288 new colorectal and anal in situ carcinomas from the period 1988-1996 (63 were excluded for various reasons). In all, 225 new colorectal high-grade adenomas were considered. There were 129 men (57%) and 96 women (42%), and 78% of patients were aged over 60 years. Over this period we found an increase in incidence of high-grade colorectal adenomas (11 cases in 1988, 40 cases in 1996) for both sexes. The overall incidence rate was 2.9 x 100,000 in 1988 and 9.6 x 100,000 in 1996. The average annual age-standardized incidence rate for this period was 3.7+/-0.5 (95% confidence interval); the cumulative rate (0-74 years) was 0.4%. Three-fourths of the adenomas were situated in the rectum (n=78, 35%) or sigmoid colon (n=92, 41%). Histological diagnosis was provided by 160 total polypectomy specimens (71%), 30 surgical resections (13.3%), and 35 biopsy specimens (16%). Over the study period there was an increased incidence of new colorectal adenocarcinomas. There were eight times as many adenocarcinomas (n=1782) as adenomas (n=225); the distribution of anatomical sites was comparable. These epidemiological data on 225 new colorectal high-grade adenomas can be the basis for quality assurance in clinical and histological diagnostic procedures, especially in regard to the 1:8 ratio between high-grade adenomas and invasive adenocarcinomas and may provide additional data for the design of a regional or national colorectal cancer screening program.

Entities:  

Mesh:

Year:  2000        PMID: 10766088     DOI: 10.1007/s003840050004

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  4 in total

Review 1.  Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Authors:  Tuan A Dinh; Peter Alperin; Louise C Walter; Robert Smith
Journal:  J Gen Intern Med       Date:  2012-01-12       Impact factor: 5.128

2.  Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study.

Authors:  Yousef Bafandeh; Manoochehr Khoshbaten; Amir-Taher Eftekhar Sadat; Sara Farhang
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

3.  Rectal cancer in Luxembourg : a national population-based data report, 1988-1998.

Authors:  René Scheiden; Julien Sand; Joseph Weber; Philippe Turk; Yolande Wagener; Catherine Capesius
Journal:  BMC Cancer       Date:  2003-10-21       Impact factor: 4.430

4.  Premalignant lesions as targets for cancer vaccines.

Authors:  Olivera J Finn
Journal:  J Exp Med       Date:  2003-11-24       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.